Disruptions in LPCAT-related pathways have been implicated in the development of various diseases, including respiratory distress syndrome, diabetes mellitus, high cholesterol, non-alcoholic fatty liver disease, inflammatory disorders, and even some cancers [32–35]. The gene discussed is LPCAT1; the disease is metabolic dysfunction-associated steatotic liver disease.